|
|
|
|
Paroxetine-related tremor
Paroxetine is a phenylpiperidine derivative and is the most potent inhibitor of the reuptake of serotonin (5-HT) of all available antidepressants, including the SSRI class. Paroxetine is approved for the treatment of depression, obsessive-compulsive disorder, panic disorder, and social phobia. It is also used in the treatment of generalized anxiety disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, and chronic headache. While paroxetine can significantly improve mood, side effects such as tremor can be disabling.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sexual dysfunction in the older woman
Sexuality is a normal part of life and, when diminished, hinders the quality of existence. Physiologic, societal, and psychological forces combine to impair sexual functioning in older women. Social stigma, lack of an available partner, and self-consciousness about physical appearance may discourage sexual expression in women.
|
| |
More>>
|
|
|
|
|
|
Partial remission: A common outcome in older adults treated for major depression
Major depression can affect up to 10% of older adults in clinical samples. Longitudinal studies of older adults with major depression report that a significant proportion of patients do not fully recover. Partial remission, or symptoms of major depression that do not meet criteria for major depression, is predicted by 1) clinical factors , such as higher number of symptoms at diagnosis, presence of comorbid dysthymia, and health problems; 2) social variables, such as high levels of perceived stress and low levels of perceived social support; and 3) perceived health/well-being variables, such as limitations in mobility or instrumental activities of daily living, poorer self-perceived health, finding life not satisfying, and looking back over life and finding it unhappy. Treatment options include antidepressants (alone or in combination) and psychotherapy.
|
| |
More>>
|
|
|
|
|
|
Non-elderly patients with overactive bladder have significant comorbidities
A study was conducted to evaluate the clinical and economic burden of overactive bladder (OAB) among patients <60 years of age in a managed care population, especially with regard to the prevalence of related comorbidities and associated annual medical costs.
|
| |
More>>
|
|
|
|
|
|
Assessing older drivers
Most articles on elder drivers offer either general advice, or review testing protocols that divide drivers into two distinct groups: safe or unsafe. We believe it is unreasonable to expect any testing to fully separate drivers into just these two mutually exclusive groups, so we offer a protocol for a more practical approach.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
|